H2S is a gaseous signaling molecule, a vasodilator and a potent cardiovascular protective agent
Semaglutide and tirzepatide achieve approximately 15-20% body weight reduction in clinical trials
Safety Monitoring, Follow-up Protocols, and Who Should Start GLP-1 Both Shedrx and LifeMD should offer structured follow-up protocols at 24 weeks post-initiation and ongoing check-ins to assess tolerability, side effects, and metabolic response
Thicker needles (29 gauge) allow faster injection but may cause slightly more sensation at the injection site
Topic Q&A will close to new questions on August 21, 2024, but will remain active for viewing until the BAA closes
If your New Year goals include feeling better in your body without turning food into a battlefield, Sheds reset might be worth a closer look